Catheter Precision Initiates LockeT Compare Study to Evaluate Safety of External Suture Retention Device
核心洞察
Catheter Precision has enrolled the first three patients in the LockeT (搜索) Compare Study, a single-center physician-initiated trial evaluating up to 100 patients.
The study compares the safety profile of LockeT (搜索) suture retention device against internal closure devices for managing groin complications after cardiac catheter procedures.
Previous clinical data demonstrates that LockeT (搜索) is safe, effective, and reduces procedural costs while maintaining current hospital workflows.
Catheter Precision, Inc. has announced the enrollment of the first three patients in the LockeT (搜索) Compare Study, marking a significant milestone in evaluating the safety profile of its external suture retention device for cardiac catheterization procedures. The single-center, physician-initiated study will enroll up to 100 patients to compare LockeT's safety profile against internal closure devices.
Study Design and Objectives
The LockeT (搜索) Compare Study addresses a critical clinical need in cardiac electrophysiology procedures. Groin complications following cardiac catheter procedures, including atrial fibrillation (搜索), are common occurrences that can range from minor bruising to serious events such as embolism (搜索). The study specifically evaluates whether LockeT's external closure mechanism offers safety advantages over traditional internal closure devices.
According to David Jenkins, CEO of Catheter Precision, "Effective groin management at the access site after a cardiac catheter procedure, is just as important as the procedure outcomes." The company has positioned this study to demonstrate potential reductions in thrombotic episodes compared to devices with internal closure mechanisms.
Device Profile and Clinical Evidence
LockeT (搜索) is classified as a Class 1 device registered with the FDA and has received CE Mark approval. The suture retention device is designed to assist in wound closure after percutaneous venous punctures, functioning as an external hemostasis solution. Previous clinical data has demonstrated that LockeT is safe, effective, and reduces procedural costs without requiring changes to current hospital practices and workflows.
The device's external mechanism represents a departure from traditional internal closure approaches. Jenkins stated, "We have successfully shown that LockeT (搜索) creates hemostasis as an external device and believe that this study will also show that there is a reduction in thrombotic episodes compared to closure devices that have an internal closure mechanism, thus improving patient safety."
Market Context and Company Background
Catheter Precision operates as a U.S.-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market. The company's approach centers on collaborating with physicians and continuously advancing products to improve the treatment of cardiac arrhythmias (搜索) through groundbreaking electrophysiology procedure technology.
The LockeT (搜索) Compare Study represents the company's continued commitment to evidence-based development, building upon existing clinical data that supports the device's safety and effectiveness profile. The study's physician-initiated design reflects clinical interest in evaluating alternative approaches to post-procedural groin management in cardiac catheterization.